The Johnson & Johnson jab is a game changer
Good vaccine news has been pouring in today — this afternoon it was the turn of the Janssen vaccine, made by US company Johnson & Johnson. An international trial, in which the vaccine was tested against various strains of the virus, has found the jab to have 66 per cent overall efficacy. This is a lower efficacy rate than the trial conducted in the United States — which found the jab to be 72 per cent effective. But the international trial was designed to test the vaccine against more aggressive strains of the virus in a bid to answer questions about the new mutations. The trail set up sites in ‘red list’
